News and Trends 29 Jun 2022
ARCH Venture Partners launches $3B fund for biotech companies
ARCH Venture Partners has announced the closing of ARCH Venture Fund XII, with $2.975 billion to invest in the creation, development and funding of early stage biotechnology companies. The new…